1-4 of 4
Masakazu Higuchi, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Individually Tailored Treatment Strategies For Frail Myeloma Patients In Japan

Ryosuke Ogawa, MD, PhD, Takanori Ohta, MD, Kenichi Aoki, MD, Hirotake Kusumoto, MD, Mariko Minami, MD, Masakazu Higuchi, MD, PhD, Yasuhiro Sugio, MD, Yuju Ohno, MD
Journal: Blood
Blood (2013) 122 (21): 5614.
https://doi.org/10.1182/blood.V122.21.5614.5614
Published: 2013
Journal Articles

Prognostic Significance Of S-Phase Kinase-Associated Protein 2 (Skp2) In DLBCL Patients Treated With Upfront Autologous Peripheral Blood Stem Cell Transplantation

Takashi Okamura, MD, PhD, Ritsuko Seki, PhD, Koji Nagafuji, MD, PhD, Kisato Nosaka, MD, PhD, Takeshi Tsuchiya, MD, PhD, Hiroyuki Tsuda, M.D, PhD, Toshihiro Miyamoto, MD, Masakazu Higuchi, MD, PhD, Hitoshi Suzushima, MD, PhD, Michihiro Hidaka, MD, PhD, Abe Yasunobu, MD, PhD, Yuji Yufu, MD, PhD, Yutaka Imamura, MD, PhD, Masahiro Iwahashi, MD, PhD, Tomoaki Fujisaki, MD, PhD, Naokuni Uike, MD, PhD, Moriuchi Yukiyoshi, MD, PhD, Tetsuya Eto, MD, PhD, Gondo Hisashi, MD, PhD, Tomohiko Kamimura, MD PhD, Yasushi Takamatsu, MD, PhD, Ohshima Koichi, MD PhD
Journal: Blood
Blood (2013) 122 (21): 3022.
https://doi.org/10.1182/blood.V122.21.3022.3022
Published: 2013
Journal Articles

Minimal Residual Disease Negative Status At the End of Induction Therapy Is a Potent Prognostic Marker in Adult Non-Ph Acute Lymphoblastic Leukemia: Results of the ALL MRD2002 Study

Koji Nagafuji, MD, PhD, Toshihiro Miyamoto, MD, PhD, Tetsuya Eto, MD, PhD, Tomohiko Kamimura, MD, Shuichi Taniguchi, MD, PhD, Takashi Okamura, MD, PhD, Eiichi Ohtsuka, MD, PhD, Takashi Yoshida, MD, Masakazu Higuchi, MD, PhD, Goichi Yoshimoto, MD, PhD, Tomoaki Fujisaki, MD, PhD, Yasunobu Abe, MD, PhD, Yasushi Takamatsu, MD, PhD, Shouhei Yokota, MD, PhD, Koichi Akashi, MD, PhD., Mine Harada, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2581.
https://doi.org/10.1182/blood.V118.21.2581.2581
Published: 2011
Journal Articles

A Phase I/II Study of Bortezomib in Combination with Doxorubicin and Intermediate-Dose Dexamethasone (iPAD therapy) for Relapsed or Refractory Multiple Myeloma

Yasushi Takamatsu, MD, PhD, Kazutaka Sunami, MD, PhD, Tsuyoshi Muta, MD, PhD, Junichi Tsukada, MD, PhD, Toshihiro Miyamoto, MD, PhD, Tetsuya Eto, MD, PhD, Masakazu Higuchi, MD, PhD, Hiroyuki Hata, MD, PhD, Junji Suzumiya, MD, PhD, Kazuo Tamura, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 5137.
https://doi.org/10.1182/blood.V118.21.5137.5137
Published: 2011